Literature DB >> 23568088

Guidelines for the use of 18F-FDG in infection and inflammation: a new step in cooperation between the EANM and SNMMI.

J Buscombe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23568088     DOI： 10.1007/s00259-013-2380-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  11 in total

1.  FDG-PET in infectious and inflammatory disease.

Authors:  Wim J G Oyen; Luigi Mansi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-02       Impact factor: 9.236

2.  FDG-PET in infectious and inflammatory disease.

Authors:  J Buscombe; A Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-02       Impact factor: 9.236

3.  SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0.

Authors:  Stanley J Goldsmith; Ward Parsons; Milton J Guiberteau; Lillian H Stern; Leora Lanzkowsky; Jean Weigert; Thomas F Heston; Elizabeth Jones; Jonathan Buscombe; Michael G Stabin
Journal:  J Nucl Med Technol       Date:  2010-11-05

4.  A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.

Authors:  Chantal P Bleeker-Rovers; Fidel J Vos; Elisabeth M H A de Kleijn; Aart H Mudde; Ton S M Dofferhoff; Clemens Richter; Tineke J Smilde; Paul F M Krabbe; Wim J G Oyen; Jos W M van der Meer
Journal:  Medicine (Baltimore)       Date:  2007-01       Impact factor: 1.889

5.  Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot?

Authors:  Demetrio Familiari; Andor W J M Glaudemans; Valeria Vitale; Daniela Prosperi; Oreste Bagni; Andrea Lenza; Marco Cavallini; Francesco Scopinaro; Alberto Signore
Journal:  J Nucl Med       Date:  2011-06-16       Impact factor: 10.057

6.  EANM/SNMMI guideline for 18F-FDG use in inflammation and infection.

Authors:  Francois Jamar; John Buscombe; Arturo Chiti; Paul E Christian; Dominique Delbeke; Kevin J Donohoe; Ora Israel; Josep Martin-Comin; Alberto Signore
Journal:  J Nucl Med       Date:  2013-01-28       Impact factor: 10.057

7.  PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection.

Authors:  Josephine N Rini; Kuldeep K Bhargava; Gene G Tronco; Carol Singer; Russell Caprioli; Scott E Marwin; Hugh L Richardson; Kenneth J Nichols; Paul V Pugliese; Christopher J Palestro
Journal:  Radiology       Date:  2006-03       Impact factor: 11.105

8.  The diabetic foot: initial experience with 18F-FDG PET/CT.

Authors:  Zohar Keidar; Daniela Militianu; Eyal Melamed; Rachel Bar-Shalom; Ora Israel
Journal:  J Nucl Med       Date:  2005-03       Impact factor: 10.057

9.  Fever of unknown origin: the role of 18F-FDG PET/CT.

Authors:  Zohar Keidar; Alexandra Gurman-Balbir; Diana Gaitini; Ora Israel
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

10.  18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation.

Authors:  Fidel J Vos; J Peter Donnelly; Wim J G Oyen; Bart-Jan Kullberg; Chantal P Bleeker-Rovers; Nicole M A Blijlevens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-24       Impact factor: 9.236
View more
  2 in total

1.  Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus.

Authors:  Mette Bordinggaard Brøndserud; Court Pedersen; Flemming S Rosenvinge; Poul F Høilund-Carlsen; Søren Hess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-02-20       Impact factor: 9.236

2.  The difference between steroid diabetes mellitus and type 2 diabetes mellitus: a whole-body 18F-FDG PET/CT study.

Authors:  Qingqing Zhao; Jinxin Zhou; Yu Pan; Huijun Ju; Liying Zhu; Yang Liu; Yifan Zhang
Journal:  Acta Diabetol       Date:  2020-07-09       Impact factor: 4.280
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.